Cat.#: ACPP-1259
| Despition | Usherin Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1341 | Pax2 Blocking Peptide (AC1341) | 250 µg | inquiry |
| ACPP-1263 | MAPK7 Blocking Peptide (AC1263) | 250 µg | inquiry |
| ACPP-1797 | Human S100A5 Protein (AC1797) | 5 µg | inquiry |
| ACPP-1097 | Synthetic Nanodisc Human ENTPD2 Protein (AC1097) | 10 µg | inquiry |
| ACPP-1768 | Human SNAP25 Protein (AC1768) | 5 µg | inquiry |
| ACPP-1680 | Human DOK4 Protein (AC1680) | 5 µg | inquiry |
| ACPP-1328 | MRAP2 Blocking Peptide (AC1328) | 250 µg | inquiry |
| ACPP-1246 | Bestrophin Blocking Peptide (AC1246) | 250 µg | inquiry |
| ACPP-1777 | Human Acrp30 Protein (AC1777) | 5 µg | inquiry |
| ACPP-1377 | Human KCNMB3 Protein (AC1377) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.